Doximity, Inc. (DOCS)
NYSE: DOCS · Real-Time Price · USD
66.95
+0.95 (1.44%)
At close: Nov 3, 2025, 4:00 PM EST
66.40
-0.55 (-0.82%)
After-hours: Nov 3, 2025, 4:41 PM EST
Doximity Revenue
Doximity had revenue of $145.91M in the quarter ending June 30, 2025, with 15.19% growth. This brings the company's revenue in the last twelve months to $589.64M, up 19.45% year-over-year. In the fiscal year ending March 31, 2025, Doximity had annual revenue of $570.40M with 19.98% growth.
Revenue (ttm)
$589.64M
Revenue Growth
+19.45%
P/S Ratio
20.98
Revenue / Employee
$710,405
Employees
830
Market Cap
12.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 570.40M | 94.98M | 19.98% |
| Mar 31, 2024 | 475.42M | 56.37M | 13.45% |
| Mar 31, 2023 | 419.05M | 75.50M | 21.98% |
| Mar 31, 2022 | 343.55M | 136.65M | 66.05% |
| Mar 31, 2021 | 206.90M | 90.51M | 77.76% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
DOCS News
- 10 days ago - Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 18 days ago - Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025 - Business Wire
- 4 weeks ago - Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation - Business Wire
- 3 months ago - Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings - Benzinga
- 3 months ago - Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers - CNBC
- 3 months ago - Doximity Acquires Pathway, a Leader in AI Clinical Reference - Business Wire
- 3 months ago - Doximity Announces Fiscal 2026 First Quarter Financial Results - Business Wire